SARS-CoV2 disease seen through the prism of acutely decompensated chronic kidney disease and ischemic stroke: What lesson we have learned from using prophylaxis therapy of vascular thromboembolism?

Asmaa Hazim; Jehanne Aasfara; Ilham Slassi; Bernard Canaud; Amal Haoudar; Abdelhamid Naitlhou; Chafik El Kettani

doi:10.1002/ccr3.3385

SARS-CoV2 disease seen through the prism of acutely decompensated chronic kidney disease and ischemic stroke: What lesson we have learned from using prophylaxis therapy of vascular thromboembolism?

Clin Case Rep. 2020 Oct 7;8(12):3229-3233. doi: 10.1002/ccr3.3385. eCollection 2020 Dec.

Authors

Asmaa Hazim¹, Jehanne Aasfara¹, Ilham Slassi¹, Bernard Canaud², Amal Haoudar³, Abdelhamid Naitlhou⁴, Chafik El Kettani³

Affiliations

¹ Neurology Cheikh Khalifa Ibn Zayed hospital Mohammed VI University of Health Sciences Casablanca Morocco.
² Nephrology UFR, Medicine Department Faculty Member Montpellier University Montpellier France.
³ Anesthesiology-Reanimation Cheikh Khalifa Ibn Zayed hospital Mohammed VI University of Health Sciences Casablanca Morocco.
⁴ Internal Medicine Cheikh Khalifa Ibn Zayed hospital Mohammed VI University of Health Sciences Casablanca Morocco.

Abstract

Our case underlines the tight management of antithrombotic therapy in the context of acutely decompensated chronic kidney disease, ischemic stroke, and SARS-CoV2 infection, the development of stroke as a SARS-CoV2 complication increase the chances of adverse outcomes that may be mitigated by a rapid recognition and institution of available treatments.

Keywords: SARS‐CoV2; acute kidney injury; chronic kidney disease; ischemic stroke; vascular thromboembolism anticoagulation.

Publication types

Case Reports